March 18, 2016 | Decision-making, Pegasus
To reflect the importance of self-care in health, we developed and launched a new model for exploring personal health decision-making which provides a framework for strategic planning, whatever the therapy area. That model is called Healthscapes, the product of an extensive academic literature review, focus groups and a questionnaire among 10,000 people.
When used in conjunction with our Pegasus Panel, a bespoke database of industry experts, healthcare professionals and media consultants, Healthscapes improves the depth of exploration and the quality of insight generated and forms the backbone of our planning approach.
Find out more at info@thisispegasus.co.uk or by calling +44 (0) 1273 712 000.
This content was provided by Inizio
Latest Content from Inizio
Our client wanted to identify the optimum selling price for their chronic disease treatment in emerging markets, based on patient’s willingness to pay for the product out of pocket.Find out…
Our latest white paper on immuno-oncology explores the challenges and opportunities in emerging markets, with a focus on Asia.
Pegasus received three top accolades at the PM Society Digital Media Awards 2016, including gold for the highly acclaimed Craft: Best Innovation award with Biogen’s MS Explorer, and two silvers…
We’ve built a new type of health communications consultancy. One that believes in a ‘health first, sector second’ approach. One that connects with every stakeholder. One that blends traditional, digital…
To reflect the importance of self-care in health, we developed and launched a new model for exploring personal health decision-making which provides a framework for strategic planning, whatever the therapy…
Telling a health message is one half of the battle. Ensuring that these messages resonate is another matter entirely. The Lab is our 25-strong, in-house creative and content team within…
Pegasus, the UK’s leading independent health communications consultancy, has had recognition of its work in digital media with shortlistings for four awards at the PM Society Digital Media Awards 2016…
Research findings from our Therapy HCV study shows that 28% of HCV patients in the EU are infected by sharing needles or drug equipment.Our latest market snapshot offers an introduction…
Published in eyeforpharma February 2016 by Rachel Howard
Often a short research study isn’t sufficient to get the level of insights and understanding that you require, especially when working with a hard to reach target audience.It can also…
